Fortress Biotech Inc Market Cap ($65.44 Million)
Market Cap & Net Worth: Fortress Biotech Inc (FBIO)
Fortress Biotech Inc market cap. Fortress Biotech Inc (NASDAQ:FBIO) has a market capitalization of $65.44 Million ($65.44 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20669 globally and #4688 in its home market, demonstrating a 2.07% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fortress Biotech Inc's stock price $1.97 by its total outstanding shares 33219072 (33.22 Million). Also see cash efficiency ratio of Fortress Biotech Inc for how efficiently the company converts equity into cash flow.
Fortress Biotech Inc Market Cap History (2015–2026)
Fortress Biotech Inc market cap history from 2015 to 2026. Data shows change from $1.39 Billion to $65.44 Million (-24.33% CAGR). Check FBIO live share price for real-time trading data and today's change.
Index Memberships
Fortress Biotech Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.00% | #584 of 976 |
|
NASDAQ Composite
IXIC
|
$40.12 Trillion | 0.00% | #1974 of 3165 |
Weight: Fortress Biotech Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Fortress Biotech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fortress Biotech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Fortress Biotech Inc growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.92x
Fortress Biotech Inc's market cap is 1.92 times its annual revenue
Latest Price to Earnings (P/E) Ratio
17.84x
Fortress Biotech Inc's market cap is 17.84 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.35 Billion | $16.48 Million | -$55.09 Million | 81.64x | N/A |
| 2017 | $1.99 Billion | $187.58 Million | -$66.88 Million | 10.60x | N/A |
| 2018 | $428.53 Million | $26.88 Million | -$84.15 Million | 15.94x | N/A |
| 2019 | $1.28 Billion | $36.63 Million | -$39.96 Million | 34.96x | N/A |
| 2020 | $1.58 Billion | $45.60 Million | -$46.53 Million | 34.64x | N/A |
| 2021 | $1.25 Billion | $68.79 Million | -$64.70 Million | 18.11x | N/A |
| 2022 | $328.87 Million | $75.74 Million | -$86.58 Million | 4.34x | N/A |
| 2023 | $99.99 Million | $84.51 Million | -$60.64 Million | 1.18x | N/A |
| 2024 | $67.27 Million | $57.67 Million | -$46.00 Million | 1.17x | N/A |
| 2025 | $121.58 Million | $63.26 Million | $6.82 Million | 1.92x | 17.84x |
Competitor Companies of FBIO by Market Capitalization
Companies near Fortress Biotech Inc in the global market cap rankings as of November 5, 2026. Also see Fortress Biotech Inc (FBIO) total assets for a full breakdown of the balance sheet.
Key companies related to Fortress Biotech Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #181 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #373 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #415 globally with a market cap of $67.74 Billion USD ( AU$95.74 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #503 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #181 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $549.04 |
| #373 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $930.67 |
| #415 | CSL Ltd | AU:CSL | $67.74 Billion | AU$197.34 |
| #503 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $258.38 |
Market Capitalization of Fortress Biotech Inc (2015–2026)
Market capitalization of Fortress Biotech Inc from 2015 to today. Between 2015 and today, Fortress Biotech Inc's market cap moved from $1.39 Billion to $ 65.44 Million, with a yearly change of -24.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $65.44 Million | -46.17% |
| 2025 | $121.58 Million | +80.74% |
| 2024 | $67.27 Million | -32.72% |
| 2023 | $99.99 Million | -69.60% |
| 2022 | $328.87 Million | -73.60% |
| 2021 | $1.25 Billion | -21.14% |
| 2020 | $1.58 Billion | +23.35% |
| 2019 | $1.28 Billion | +198.84% |
| 2018 | $428.53 Million | -78.45% |
| 2017 | $1.99 Billion | +47.78% |
| 2016 | $1.35 Billion | -3.23% |
| 2015 | $1.39 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Fortress Biotech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $65.44 Million USD |
| MoneyControl | $65.44 Million USD |
| MarketWatch | $65.44 Million USD |
| marketcap.company | $65.44 Million USD |
| Reuters | $65.44 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Fortress Biotech Inc
Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane, an oral isotretinoin drug for the treatment of severe recalc… Read more